Projects and Grants per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Doctor of Pharmacy, Medical University of South Carolina
1990
Bachelor of Science in Pharmacy, Unspecified
1987
Fingerprint
Dive into the research topics where David Burgess is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
ALN 47.041: PIPP Phase II: Environmental Surveillance for Assessing Pathogen Emergence (ESCAPE)
Berry, S. (PI), Burgess, D. (CoI), Hoover, A. (CoI) & Messer, T. (CoI)
9/1/24 → 8/31/31
Project: Research project
-
PIPP Phase II: Environmental Surveillance for Assessing Pathogen Emergence (ESCAPE)
Berry, S. (PI), Alameh, S. (CoI), Arora, V. (CoI), Burgess, D. (CoI), Gallimore, J. (CoI), Hoover, A. (CoI), Messer, T. (CoI), Ormsbee, L. (CoI) & Xiang, L. (CoI)
9/1/24 → 8/31/31
Project: Research project
-
Central Nervous System Penetration and Plasma Pharmacokinetics of Telavancin in Critically Ill Patients
Cook, A. (PI) & Burgess, D. (CoI)
Cumberland Pharmaceuticals Inc
10/11/23 → 10/11/25
Project: Research project
-
COBRE in Pharmaceutical Research and Innovation
Thorson, J. (PI), Helmy, Y. A. (CoI), Jaramillo, A. (CoI), She, Q.-B. (CoI), Adams, V. (Former CoI), Alam, M. (Former CoI), Awuah, S. (Former CoI), Bardo, M. (Former CoI), Bauer, B. (Former CoI), Burgess, D. (Former CoI), Czuba, L. (Former CoI), Daugherty, A. (Former CoI), Dwoskin, L. (Former CoI), Feola, D. (Former CoI), Garneau-Tsodikova, S. (Former CoI), Gensel, J. (Former CoI), Glazer, E. (Former CoI), Grady, M. (Former CoI), Graf, G. (Former CoI), Kapur, N. (Former CoI), Kolesar, J. (Former CoI), Korotkov, K. (Former CoI), Korotkova, N. (Former CoI), Leggas, M. (Former CoI), Mahmoud, K. A. (Former CoI), McLaurin, K. (Former CoI), Messaoudi Powers, I. (Former CoI), Nikolajczyk, B. (Former CoI), Ortinski, P. (Former CoI), Pack, D. (Former CoI), Park, J. (Former CoI), Prisinzano, T. (Former CoI), Richards, C. (Former CoI), Rohr, J. (Former CoI), Sen, P. (Former CoI), Shaffer, C. (Former CoI), Stevenson, B. (Former CoI), Sturgill, J. (Former CoI), Sviripa, V. (Former CoI), Tidgewell, K. (Former CoI), Tiruvannamalai Annam, R. (Former CoI), Turner, J. (Former CoI), Van Lanen, S. (Former CoI), Venditto, V. (Former CoI), Watt, D. (Former CoI), Webb, N. (Former CoI) & Zhan, C.-G. (Former CoI)
National Institute of General Medical Sciences
3/1/20 → 1/31/26
Project: Research project
-
Implementing a pharmacist-managed personalized medicine dosing protocol for beta-lactam antibiotics in critically ill patients: a prospective observational pilot study.
Olney, K. (PI), Burgess, D. (CoI), Cook, A. (CoI), Bastin, M. T. (Former PI), DeSalvo, A. (Former CoI), Flannery, A. (Former CoI), Morris, P. (Former CoI), Neyra Lozano, J. (Former CoI), Schadler, A. (Former CoI) & Schuler, E. (Former CoI)
American Society of Health-System Pharmacists
7/1/18 → 3/31/25
Project: Research project
-
Comparing the activity of broad-spectrum beta-lactams in combination with aminoglycosides against VIM-producing Enterobacteriaceae
Clark, J. A. & Burgess, D. S., Oct 2024, In: Microbiology spectrum. 12, 10Research output: Contribution to journal › Article › peer-review
Open Access -
Daptomycin Dose Optimization in Pediatric Staphylococcus aureus Bacteremia: A Pharmacokinetic/Pharmacodynamic Investigation
Olney, K. B., Howard, J. I. & Burgess, D. S., Jul 2024, In: Journal of Clinical Pharmacology. 64, 7, p. 860-865 6 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections
Olney, K. B., Pai, M. P., Thomas, J. K., Burgess, D. R., Olney, W. J., Bruning, R. A., Griffith, K. A., Casaus, D. V., Crance, E., Porterfield, J. Z. & Burgess, D. S., Aug 2024, In: Pharmacotherapy. 44, 8, p. 615-622 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Performance of ePlex® blood culture identification panels in clinical isolates and characterization of antimicrobial stewardship opportunities
Thomas, J. K., Clark, J., Arora, V., Burgess, D. S., Burgess, D. R., Mynatt, R. P., VanHoose, J. D., Wallace, K. L. & Cotner, S. E., Jul 2024, In: Diagnostic Microbiology and Infectious Disease. 109, 3, 116269.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
The effect of carbapenem-resistant versus carbapenem-susceptible Enterobacterales infections on patient outcomes at an academic medical center
Clark, J. A., Burgess, D. S. & Moga, D., Oct 25 2024, In: Antimicrobial Stewardship and Healthcare Epidemiology. 4, 1, e189.Research output: Contribution to journal › Article › peer-review
Open Access